Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma-Reference-Cited by-同舟云学术

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma

Published:2017-07 Issue:1 Volume:67 Page:65-71
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Cabibbo Giuseppe,Petta Salvatore,Barbara Marco,Attardo Simona,Bucci Laura,Farinati Fabio,Giannini Edoardo G.,Negrini Giulia,Ciccarese Francesca,Rapaccini Gian Lodovico,Di Marco Maria,Caturelli Eugenio,Zoli Marco,Borzio Franco,Sacco Rodolfo,Virdone Roberto,Marra Fabio,Mega Andrea,Morisco Filomena,Benvegnù Luisa,Gasbarrini Antonio,Svegliati-Baroni Gianluca,Foschi Francesco Giuseppe,Olivani Andrea,Masotto Alberto,Nardone Gerardo,Colecchia Antonio,Persico Marcello,Craxì Antonio,Trevisani Franco,Cammà Calogero

Publisher

Elsevier BV

Subject

Hepatology

Reference33 articles.

1. Effects of eradicating hepatitis C virus infection in patients with cirrhosis differ with stage of portal hypertension;Di Marco;Gastroenterology,2016

2. Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications;Nahon;Gastroenterology,2017

3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2012

4. KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma;Gut Liver,2015

5. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma;Bruix;Gastroenterology,2016

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation;Alimentary Pharmacology & Therapeutics;2024-08-07

2. Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment;Hepatology;2024-07-19

3. Achieving SVR in patients with hepatitis C-related HCC is associated with an improvement in overall survival: real word data;Hepatoma Research;2024-07-11

4. Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study;2024-06-10

5. Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice;Journal of Hepatology;2024-06